Finch Therapeutics Group, Inc. (FNCH)
NASDAQ: FNCH · IEX Real-Time Price · USD
1.940
-0.010 (-0.51%)
At close: May 17, 2024, 4:00 PM
1.870
-0.070 (-3.61%)
After-hours: May 17, 2024, 4:08 PM EDT
Finch Therapeutics Group Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for FNCH.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for FNCH.
Recommendation Trends
Rating | Dec '22 | Jan '23 | Feb '23 | Mar '23 | Apr '23 | May '23 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $210 | Strong Buy | Reiterates | $210 | +10,724.74% | May 12, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $510 → $210 | Strong Buy | Reiterates | $510 → $210 | +10,724.74% | Apr 4, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $510 | Strong Buy | Initiates | $510 | +26,188.66% | Aug 9, 2022 |
Jefferies | Jefferies | Strong Buy Maintains $870 → $510 | Strong Buy | Maintains | $870 → $510 | +26,188.66% | Apr 4, 2022 |
Evercore ISI Group | Evercore ISI Group | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Apr 13, 2021 |
Financial Forecast
Revenue This Year
n/a
from 107.00K
Revenue Next Year
90.27M
EPS This Year
-21.00
from -46.59
EPS Next Year
n/a
from -21.00
Revenue Forecast
Revenue | 2024 | 2025 |
---|---|---|
High | n/a | 92.9M |
Avg | n/a | 90.3M |
Low | n/a | 86.7M |
Revenue Growth
Revenue Growth | 2024 | 2025 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
EPS Forecast
EPS | 2024 |
---|---|
High | -21.62 |
Avg | -21.00 |
Low | -20.18 |
EPS Growth
EPS Growth | 2024 |
---|---|
High | - |
Avg | - |
Low | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.